| Miss Emily Newquist, PHARMD | |
|
901 E Crawford St, Salina, KS 67401-5100 | |
| (785) 827-0408 | |
| (785) 827-8371 |
| Full Name | Miss Emily Newquist |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 901 E Crawford St, Salina, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265956650 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-102941 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Emily Newquist, PHARMD 829 E Cloud St, Salina, KS 67401-6419 Ph: () - | Miss Emily Newquist, PHARMD 901 E Crawford St, Salina, KS 67401-5100 Ph: (785) 827-0408 |
News Archive
Mild cognitive impairment (MCI) is often considered an early symptom of Alzheimer's disease (AD). An analysis of genetic risk factors predisposing to MCI is critical for accessing individual predisposition and reliably evaluating the effectiveness of early treatment. In a groundbreaking study published in the February 2010 issue of the Journal of Alzheimer's Disease investigators successfully used artificial neural networks (ANNs) to help understand the causal relation between multiple factors and the occurrence of neurodegenerative disorders.
Although it's been clear that seizures are linked to memory loss and other cognitive deficits in patients with Alzheimer's disease, how this happens has been puzzling. In a study published in the journal Nature Medicine, a team of researchers reveals a mechanism that can explain how even relatively infrequent seizures can lead to long-lasting cognitive deficits in animal models.
A new article available online in the American Journal of Public Health by two Johns Hopkins Bloomberg School of Public Health faculty makes a compelling case that end-of-life care issues need to become an integral part of the public health agenda.
BerGenBio AS, an oncology biopharmaceutical company, today announces that an abstract on the latest data on BGB324, the Company's first-in-class, selective small molecule inhibitor of the Axl receptor tyrosine kinase, and BGB10C9, an Axl function-blocking monoclonal antibody in pre-clinical development at BerGenBio, has been published in conjunction with the 2015 American Society of Clinical Oncology Annual Meeting in Chicago, May 29 - June 2, 2015.
› Verified 3 days ago
Jerry Franklin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 809 Elmhurst Blvd, Suite A, Salina, KS 67401 Phone: 785-914-5491 | |
Carleigh Cozad, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 S 9th St, Salina, KS 67401 Phone: 785-825-4449 | |
Thomas Robert Katafiasz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 S Broadway Blvd, Salina, KS 67401 Phone: 785-825-2248 Fax: 785-825-0455 | |
Vinh Duc Ha, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 S Santa Fe Ave Ste 1121a, Salina, KS 67401 Phone: 785-452-7531 | |
James Cram, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 650 Rockview Rd, Salina, KS 67401 Phone: 785-825-6014 Fax: 877-297-4979 | |
Erin Conner-desilvey, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2919 Market Pl, Salina, KS 67401 Phone: 785-823-7641 Fax: 785-823-7377 | |
Dr. Linda Y. Radke, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 S Santa Fe Ave, Salina, KS 67401 Phone: 785-452-7705 Fax: 785-452-6945 |